Literature DB >> 15338283

Cytokine and antibody production during the course of resolution in Plasmodium yoelii 17XL-infected BALB/c mice treated with febrifugine and isofebrifugine mixture from leaves of Hydrangea macrophylla var. Otaksa.

A Ishih1, T Nagata, F Kobayashi, T Miyase, M Terada.   

Abstract

Cytokine and antibody production was investigated during the course of resolution of primary infection in Plasmodium yoelii 17XL-infected BALB/c mice treated with a mixture of febrifugine and isofebrifugine. The infected mice in an untreated control group showed a progressively increasing parasitemia, leading to mouse death. In contrast, infected mice given the mixture orally showed low parasitemia levels during administration. Following a transient increase in parasitemia in the bloodstream of the treated mice, no parasites could be detected by microscopic examination. Analysis of cytokines in plasma showed that the plasma IFN-gamma levels elevated significantly within the first week of infection in both groups. Furthermore, on day 20 the plasma IFN-gamma and IL-4 levels elevated significantly in the treated mice and the production of both cytokines was sustained until at least day 40. The production of both cytokines in the treated mice was coincident with a decrease in parasitemia. The production of parasite-specific antibodies in the course of P. yoelii 17XL infection was also monitored. In the drug-treated mice, the titers of parasite-specific IgG1, IgG2a, IgG2b and IgG3 elevated significantly from day 20; and the production of parasite-specific antibodies was coincident with a decrease in parasite numbers in the bloodstream.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15338283     DOI: 10.1007/s00436-004-1187-4

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  22 in total

1.  T-cell activation in murine malaria.

Authors:  A N Jayawardena; G A Targett; E Leuchars; R L Carter; M J Doenhoff; A J Davies
Journal:  Nature       Date:  1975-11-13       Impact factor: 49.962

Review 2.  Immunology of human malaria. A cellular perspective.

Authors:  M Ho; H K Webster
Journal:  Parasite Immunol       Date:  1989-03       Impact factor: 2.280

3.  Parasite-specific immunoglobulin isotypes during lethal and non-lethal murine malaria infections.

Authors:  Elizabeth C Smith; Andrew W Taylor-Robinson
Journal:  Parasitol Res       Date:  2002-08-24       Impact factor: 2.289

4.  Reinioses A--J, oligosaccharide multi-esters from the roots of Polygala reinii Fr. et Sav.

Authors:  H Saitoh; T Miyase; A Ueno
Journal:  Chem Pharm Bull (Tokyo)       Date:  1994-09       Impact factor: 1.645

5.  Mycobacterium bovis bacillus calmette-guérin induces protective immunity against infection by Plasmodium yoelii at blood-stage depending on shifting immunity toward Th1 type and inducing protective IgG2a after the parasite infection.

Authors:  S Matsumoto; H Yukitake; H Kanbara; H Yamada; A Kitamura; T Yamada
Journal:  Vaccine       Date:  2000-11-22       Impact factor: 3.641

6.  Early gamma interferon responses in lethal and nonlethal murine blood-stage malaria.

Authors:  J B De Souza; K H Williamson; T Otani; J H Playfair
Journal:  Infect Immun       Date:  1997-05       Impact factor: 3.441

7.  Cytokine production in lethal and non-lethal murine malaria.

Authors:  H L Shear; C Ng; Y Zhao
Journal:  Immunol Lett       Date:  1990-08       Impact factor: 3.685

8.  Dissection of strain difference in acquired protective immunity against Mycobacterium bovis Calmette-Guérin bacillus (BCG). Macrophages regulate the susceptibility through cytokine network and the induction of nitric oxide synthase.

Authors:  A Yoshida; Y Koide; M Uchijima; T O Yoshida
Journal:  J Immunol       Date:  1995-08-15       Impact factor: 5.422

9.  Protection against malaria in Aotus monkeys immunized with a recombinant blood-stage antigen fused to a universal T-cell epitope: correlation of serum gamma interferon levels with protection.

Authors:  M A Herrera; F Rosero; S Herrera; P Caspers; D Rotmann; F Sinigaglia; U Certa
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

10.  A novel adjuvant for use with a blood-stage malaria vaccine.

Authors:  J B de Souza; J H Playfair
Journal:  Vaccine       Date:  1995-10       Impact factor: 3.641

View more
  2 in total

1.  The course of a primary infection of Plasmodium yoelii 17XL in both 129S1 and IFN-γ receptor-deficient mice.

Authors:  Akira Ishih; Toshi Nagata; Fumie Kobayashi
Journal:  Parasitol Res       Date:  2012-03-06       Impact factor: 2.289

2.  Outcome of primary lethal and nonlethal Plasmodium yoelii malaria infection in BALB/c and IFN-γ receptor-deficient mice following chloroquine treatment.

Authors:  Akira Ishih; Chiri Kawakami; Atsuko Todoroki; Hiroya Hirai; Kaneo Ohori; Fumie Kobayashi
Journal:  Parasitol Res       Date:  2012-11-21       Impact factor: 2.289

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.